|Outsourcing Outlook Eric LangerCMOs Continue to Improve Overall Biomanufacturing Performance|
|Regulatory Watch Jill Wechsler FDA Overhauls Inspection Operations|
|EU Regulatory Watch Sean Milmo EU's New Telematics Strategy for the Regulation of Medicines|
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.
Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.
CDMO Xcelience opens new facility in Tampa, FL, for formulation and analytical services.